{"id":"W2766928453","doi":"10.1111/jdv.14651","title":"A phase 2a randomized controlled study to evaluate the pharmacokinetic, safety, tolerability and clinical effect of topically applied Umeclidinium in subjects with primary axillary hyperhidrosis","year":2017,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Sympathectomy and Hyperhidrosis Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"Innovaderm (Canada)","funders":"Dermira; GlaxoSmithKline","keywords":"Medicine; Tolerability; Clinical endpoint; Randomized controlled trial; Hyperhidrosis; Clinical trial; Adverse effect; Crossover study; Anesthesia; Randomization; Internal medicine; Placebo","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00346386,0.001824648,0.003941183,0.000465278,0.0006938091,0.001041206,0.001174591,0.002131172,0.009440454],"category_scores_gemma":[0.002993821,0.0009758454,0.001255061,0.0005288306,0.00134763,0.001178758,0.0003901058,0.002650143,0.001250776],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007001961,"about_ca_system_score_gemma":0.002332531,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007656994,"about_ca_topic_score_gemma":0.001812799,"domain_scores_codex":[0.9985791,0.0008209947,0.00007622479,0.0002395709,0.0001365807,0.0001475807],"domain_scores_gemma":[0.9979771,0.0006487704,0.0004786526,0.0001751554,0.0002157432,0.0005047698],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9660776,0.01857623,0.0004682365,0.0005749922,0.0005034437,0.00005235872,0.0000569192,0.0001368523,0.00489846,0.00007381038,0.0006665848,0.007914637],"study_design_scores_gemma":[0.90685,0.09150561,0.0007563647,0.00001359327,0.0001283189,0.00002226493,0.00001146293,0.000154257,0.0002088182,0.00004388825,0.0002991484,0.000006226737],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9636382,0.004929932,0.002101152,0.0009900971,0.0008845644,0.02338128,0.001687257,0.0002427938,0.002144601],"genre_scores_gemma":[0.9439183,0.003235014,0.006804123,0.002549082,0.001074287,0.03518981,0.001576979,0.00005758688,0.005594792],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009440454,"threshold_uncertainty_score":0.03158146,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02228269119199282,"score_gpt":0.3575611563178448,"score_spread":0.335278465125852,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}